JAGX — Jaguar Health, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2017-08-16.
Performance
Technicals
Others in Healthcare
Measured signals that fired on JAGX
| date | signal | measured base rate |
|---|---|---|
| 2026-03-11 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-12-11 | MICEK JOHN Director | Grant or award | 7.4K | 0.00 | 0 |
| 2025-12-11 | Wolin Jonathan S. See Remarks | Grant or award | 11.7K | 0.00 | 0 |
| 2025-12-11 | King Steven R. See Remarks | Grant or award | 11.7K | 0.00 | 0 |
| 2025-12-11 | CONTE LISA A See Remarks | Grant or award | 28.6K | 0.00 | 0 |
| 2025-12-11 | Jayasuriya Anula Director | Grant or award | 5.9K | 0.00 | 0 |
| 2025-12-11 | BOCHNOWSKI JAMES J Director | Grant or award | 6.4K | 0.00 | 0 |
| 2025-12-11 | Siegel Jonathan B. Director | Grant or award | 7.4K | 0.00 | 0 |
| 2025-12-11 | Lizak Carol R. Chief Financial Officer | Grant or award | 11.7K | 0.00 | 0 |
| 2025-12-11 | Chaturvedi Pravin R Chief Scientific Officer | Grant or award | 11.7K | 0.00 | 0 |
| 2025-05-17 | King Steven R. See Remarks | Option exercise | 1 | — | — |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| UBS Group AG | 41.8K | 112.9K |
| GEODE CAPITAL MANAGEMENT, LLC | 40.8K | 110.1K |
| TWO SIGMA SECURITIES, LLC | 4.7K | 12.6K |
| SBI Securities Co., Ltd. | 953 | 2.6K |
| Tower Research Capital LLC (TRC) | 856 | 2.3K |
| WELLS FARGO & COMPANY/MN | 74 | 200 |
| Leonteq Securities AG | 70 | 188 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 18 | 45 |
| HRT FINANCIAL LP | 5 | 15.2K |
| BlackRock, Inc. | 1 | 4 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 8-K | 2026-08-19 | 2026-08-19 | on EDGAR ↗ |
| 10-Q | 2026-08-19 | 2026-06-30 | on EDGAR ↗ |
| EFFECT | 2026-08-14 | — | on EDGAR ↗ |
| NT 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| POS AM | 2026-08-11 | — | on EDGAR ↗ |
| DEF 14A | 2026-08-03 | 2026-09-04 | on EDGAR ↗ |
| 424B3 | 2026-07-27 | — | on EDGAR ↗ |
| 424B3 | 2026-07-27 | — | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Jaguar Health, Inc. (JAGX) filed form 8-K · 2026-08-19 · SEC EDGAR
- Jaguar Health, Inc. (JAGX) filed form 8-K · 2026-08-19 · SEC EDGAR
- Jaguar Health, Inc. (JAGX) filed form 10-Q · 2026-08-19 · SEC EDGAR
- Jaguar Health, Inc. (JAGX) filed form EFFECT · 2026-08-14 · SEC EDGAR
- Jaguar Health, Inc. (JAGX) filed form NT 10-Q · 2026-08-14 · SEC EDGAR
Ask the AI about JAGX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →